Literature DB >> 20680342

Croton cajucara crude extract and isolated terpenes: activity on Trypanosoma cruzi.

Monica C O Campos1, Kelly Salomão, Denise B Castro-Pinto, Leonor L Leon, Helene S Barbosa, Maria Aparecida M Maciel, Solange L de Castro.   

Abstract

Croton cajucara is a plant found in the Amazon region and is known for its medicinal properties. The effects of the methanolic extract of the stem bark of C. cajucara (MCC) and of the isolated terpenes, trans-dehydrocrotonin (t-DCTN) and acetyl aleuritolic acid (AAA), were investigated using four isolates of Trypanosoma cruzi. In assays with trypomastigotes, the extract was more active than the isolated compounds, presenting IC(50) in the range of 10 to 50 μg/mL. The trypanocidal effect of MCC, AAA and benznidazole was significantly higher in the GLT291 and C45 strains, which were recently isolated from wild animals. MCC and AAA caused a dose-dependent inhibition of epimastigote proliferation. In assays using intracellular amastigotes, AAA and MCC reduced the percent of infection and the endocytic index after 96 h of treatment, at concentrations that were non-toxic to the host cells. MCC inhibited the trypanothione reductase pathway in both epimastigotes and trypomastigotes of all the subpopulations. The absence of AAA activity on the trypanothione reductase pathway in epimastigotes of Dm28c suggests heterogeneity of the biochemical profile between this clone and the three strains. Epimastigotes and trypomastigotes (GLT291) were treated for 24 h with MCC or AAA, and both induced alterations of the plasma membrane, while AAA-treated epimastigotes also displayed mitochondrial damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680342     DOI: 10.1007/s00436-010-1988-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  60 in total

1.  Anti-tumour activity of two 19-nor-clerodane diterpenes, trans-dehydrocrotonin and trans-crotonin, from Croton cajucara.

Authors:  N F Grynberg; A Echevarria; J E Lima; S S Pamplona; A C Pinto; M A Maciel
Journal:  Planta Med       Date:  1999-12       Impact factor: 3.352

Review 2.  Electron microscopy in antiparasitic chemotherapy: a (close) view to a kill.

Authors:  M A Vannier-Santos; S L De Castro
Journal:  Curr Drug Targets       Date:  2009-03       Impact factor: 3.465

Review 3.  Flavoprotein structure and mechanism. 5. Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design.

Authors:  R L Krauth-Siegel; R Schöneck
Journal:  FASEB J       Date:  1995-09       Impact factor: 5.191

4.  A novel icetexane diterpene, 5-epi-icetexone from Salvia gilliessi is active against Trypanosoma cruzi.

Authors:  A M Sanchez; V Jimenez-Ortiz; T Sartor; C E Tonn; E E García; M Nieto; M H Burgos; M A Sosa
Journal:  Acta Trop       Date:  2006-05-02       Impact factor: 3.112

5.  Trypanosoma cruzi infection in Leontopithecus rosalia at the Reserva Biológica de Poco das Antas, Rio de Janeiro, Brazil.

Authors:  C V Lisboa; J Dietz; A J Baker; N N Russel; A M Jansen
Journal:  Mem Inst Oswaldo Cruz       Date:  2000 Jul-Aug       Impact factor: 2.743

6.  Anti-trypanosomal activity of pentacyclic triterpenes isolated from Austroplenckia populnea (Celastraceae).

Authors:  Lucienir Pains Duarte; Sidney Augusto Vieira Filho; Grácia Divina de Fátima Silva; José Rego de Sousa; Artur da Silveira Pinto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2002 Mar-Apr       Impact factor: 1.846

Review 7.  Laboratory-acquired parasitic infections from accidental exposures.

Authors:  B L Herwaldt
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  Identifying four Trypanosoma cruzi I isolate haplotypes from different geographic regions in Colombia.

Authors:  Claudia Herrera; M Dolores Bargues; Anabella Fajardo; Marleny Montilla; Omar Triana; Gustavo Adolfo Vallejo; Felipe Guhl
Journal:  Infect Genet Evol       Date:  2006-12-28       Impact factor: 3.342

Review 9.  Trypanosoma cruzi targets for new chemotherapeutic approaches.

Authors:  Maria Nazaré C Soeiro; Solange L de Castro
Journal:  Expert Opin Ther Targets       Date:  2009-01       Impact factor: 6.902

Review 10.  In vitro approaches for determining mechanisms of toxicity and carcinogenicity by asbestos in the gastrointestinal and respiratory tracts.

Authors:  B T Mossman
Journal:  Environ Health Perspect       Date:  1983-11       Impact factor: 9.031

View more
  4 in total

1.  Effects of (1E,4E)-2-Methyl-1,5-bis(4-nitrophenyl)penta-1,4-dien-3-one on Trypanosoma cruzi and Its Combinational Effect with Benznidazole, Ketoconazole, or Fluconazole.

Authors:  Francieli Peron; Danielle Lazarin-Bidóia; Zia Ud Din; Edson Rodrigues-Filho; Tânia Ueda-Nakamura; Sueli de Oliveira Silva; Celso Vataru Nakamura
Journal:  Biomed Res Int       Date:  2017-05-23       Impact factor: 3.411

2.  Conventional therapy and promising plant-derived compounds against trypanosomatid parasites.

Authors:  Daniela Sales Alviano; Anna Léa Silva Barreto; Felipe de Almeida Dias; Igor de Almeida Rodrigues; Maria do Socorro Dos Santos Rosa; Celuta Sales Alviano; Rosangela Maria de Araújo Soares
Journal:  Front Microbiol       Date:  2012-08-06       Impact factor: 5.640

3.  Stage-regulated GFP Expression in Trypanosoma cruzi: applications from host-parasite interactions to drug screening.

Authors:  Rafael Luis Kessler; Daniela Fiori Gradia; Rita de Cássia Pontello Rampazzo; Édio Elígio Lourenço; Nilson José Fidêncio; Lauro Manhaes; Christian Macagnan Probst; Andréa Rodrigues Ávila; Stenio Perdigão Fragoso
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

4.  P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance.

Authors:  Mônica Caroline Oliveira Campos; Denise Barçante Castro-Pinto; Grazielle Alves Ribeiro; Márcia Moreira Berredo-Pinho; Leonardo Henrique Ferreira Gomes; Myrtes Santos da Silva Bellieny; Carla Marins Goulart; Aurea Echevarria; Leonor Laura Leon
Journal:  Parasitol Res       Date:  2013-04-10       Impact factor: 2.289

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.